// App-Quantinova.ai

3257 : The impact of dual targeting VEGFR2 and Tie-2 on angiogenesis using in vitro model

Researchers

Presenter

  • Khalid Alhazzani

Principal Investigators

  • Thanigaivelan Kanagasabai

  • Saad Alobid

  • Appu Rathinavelu

Medical Centers

  • College of Pharmacy, Health Professions Divison, Nova Southeastern University, Davie, FL

  • Rumbaugh Goodwin Institute for Cancer Research, Nova Southeastern University, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Kinase Insert Domain Receptor

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved